Aloka takes over U.S. sales from Corometrics

Article

Aloka announced last week that it is taking over U.S. distributionof its ultrasound scanners in ob/gyn and veterinary ultrasoundmarkets from Corometrics Medical Systems. The deal supersedesthe previous arrangement between the firms, in which Aloka

Aloka announced last week that it is taking over U.S. distributionof its ultrasound scanners in ob/gyn and veterinary ultrasoundmarkets from Corometrics Medical Systems. The deal supersedesthe previous arrangement between the firms, in which Aloka soldits scanners in radiology and intraoperative markets and Corometricsmaintained exclusive U.S. sales and marketing rights to Alokascanners in the ob/gyn and veterinary markets. Both firms arebased in Wallingford, CT.

The new structure enables the two firms to be more responsiveto customers by allowing each to focus on its core area of expertise-- Aloka in ultrasound and Corometrics in monitoring products-- according to James Pietropaolo, vice president of sales andmarketing. Corometrics will continue to provide service for allAloka ultrasound products in the U.S.

In other Aloka news, the company has announced its MultiViewupgrade for the SSD-2000 ultrasound scanners. The upgrade improvesgray-scale and color Doppler performance and includes a PowerFlowDoppler feature. All SSD-2000 units in the field are upgradableto MultiView and Aloka in August shifted production to new SSD-2000MultiView scanners.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.